← back to search

Julian Peto

Fondazione IRCCS Istituto Nazionale dei Tumori ·
Area of research
Genetics · Molecular Biology
Research interest
Research interests include BRCA gene mutations in cancer, Genetic Associations and Epidemiology, Genomics and Chromatin Dynamics, and Breast Cancer Treatment Studies.
h-index
37
citations
9,197
works
56
NIH funding
primary concept
email

Recent publications

<i>PHIP</i>- a novel candidate breast cancer susceptibility locus on 6q14.1
Oncotarget 2017cited by 14position: middledoi
RAD51B in Familial Breast Cancer
PLoS ONE 2016cited by 670position: middledoi
Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations
Cancer Research 2016cited by 119position: middledoi
Genetic predisposition to ductal carcinoma in situ of the breast
Breast Cancer Research 2016cited by 64position: middledoi
Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21
Oncotarget 2016cited by 42position: middledoi
An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression
Human Molecular Genetics 2016cited by 37position: middledoi
rs2735383, located at a microRNA binding site in the 3’UTR of NBS1, is not associated with breast cancer risk
Scientific Reports 2016cited by 4position: middledoi
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer
Nature Genetics 2015cited by 632position: middledoi
Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants
JNCI Journal of the National Cancer Institute 2015cited by 566position: middledoi
Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer
Endocrine Related Cancer 2015cited by 29position: middledoi
Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer
Carcinogenesis 2015cited by 20position: middledoi
Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium
Human Genetics 2015cited by 10position: middledoi
MicroRNA Related Polymorphisms and Breast Cancer Risk
PLoS ONE 2014cited by 638position: middledoi
Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation
Nature Communications 2014cited by 121position: middledoi
Fine-Scale Mapping of the 5q11.2 Breast Cancer Locus Reveals at Least Three Independent Risk Variants Regulating MAP3K1
The American Journal of Human Genetics 2014cited by 90position: middledoi
A Genome-wide Association Study of Early-Onset Breast Cancer Identifies <i>PFKM</i> as a Novel Breast Cancer Gene and Supports a Common Genetic Spectrum for Breast Cancer at Any Age
Cancer Epidemiology Biomarkers & Prevention 2014cited by 86position: middledoi
Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium
Human Molecular Genetics 2014cited by 59position: middledoi
Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast
PLoS Genetics 2014cited by 48position: middledoi
Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk
Human Molecular Genetics 2014cited by 45position: middledoi
Multi-stage genome-wide association study identifies new susceptibility locus for testicular germ cell tumour on chromosome 3q25
Human Molecular Genetics 2014cited by 31position: middledoi
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
Nature Genetics 2013cited by 1,105position: middledoi
Genome-wide association studies identify four ER negative–specific breast cancer risk loci
Nature Genetics 2013cited by 420position: middledoi
Evidence of Gene–Environment Interactions between Common Breast Cancer Susceptibility Loci and Established Environmental Risk Factors
PLoS Genetics 2013cited by 166position: middledoi
Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14
Nature Genetics 2013cited by 158position: middledoi
Fine-Scale Mapping of the FGFR2 Breast Cancer Risk Locus: Putative Functional Variants Differentially Bind FOXA1 and E2F1
The American Journal of Human Genetics 2013cited by 114position: middledoi
A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication
Breast Cancer Research and Treatment 2013cited by 22position: middledoi
Breast Cancer Risk and 6q22.33: Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2
PLoS ONE 2012cited by 13position: middledoi
Estimating Causal Effects of Genetic Risk Variants for Breast Cancer Using Marker Data from Bilateral and Familial Cases
Cancer Epidemiology Biomarkers & Prevention 2012cited by 7position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Janet Shipley · Institute of Cancer Research1 papers (2013–2013)Isabel dos‐Santos‐Silva · London School of Hygiene & Tropical Medicine1 papers (2012–2012)Nichola Johnson · Institute of Cancer Research1 papers (2012–2012)Rosalind A. Eeles · Meru University of Science and Technology1 papers (2013–2013) · 1 papers (2013–2013) · 1 papers (2013–2013)Clare Turnbull · Institute for Research in Schools1 papers (2013–2013)Frank Dudbridge · Universitätsmedizin Greifswald1 papers (2012–2012)Jérémie Nsengimana · Newcastle University1 papers (2013–2013)Kenneth Muir · Manchester Academic Health Science Centre1 papers (2013–2013) · 1 papers (2013–2013) · 1 papers (2013–2013)Robert Huddart · Institute of Cancer Research1 papers (2013–2013)Douglas F. Easton · Pacific Biomarkers (United States)1 papers (2013–2013)Zsofia Kote‐Jarai · Institute of Cancer Research1 papers (2013–2013)Michael R. Stratton · Colon and Rectal Surgery Associates1 papers (2013–2013)Olivia Fletcher · Institute of Cancer Research1 papers (2012–2012)Nick Orr · Queen's University Belfast1 papers (2012–2012)Kate Walker · Royal College of Surgeons of England1 papers (2012–2012) · 1 papers (2013–2013)